Nanomaterial-Based Strategies for Preventing Tumor Metastasis by Interrupting the Metastatic Biological Processes

Qingjin Cai1, Yijia He2, Yang Zhou1

  • 1Department of Urology, Urologic Surgery Center, Xinqiao Hospital, Third Military Medical University (Army Medical University), Chongqing, 400037, China.

PubMed

Insights

Nanomaterials offer a promising strategy to combat cancer metastasis by targeting key biological processes. This approach aims to prevent tumor spread and improve patient outcomes.

Area of Science:

  • Oncology
  • Materials Science
  • Nanotechnology

Background:

  • Tumor metastasis is the leading cause of cancer mortality.
  • Interrupting metastatic processes is a critical strategy for cancer treatment.
  • The tumor microenvironment (TME), circulating tumor cells (CTCs), and premetastatic niche (PMN) are key players in metastasis.

Purpose of the Study:

  • To highlight the potential of nanomaterials in targeting metastatic biological processes.
  • To explore strategies for preventing tumor metastasis using nanomaterials.
  • To discuss challenges and future prospects of nanomaterials in metastasis prevention.

Main Methods:

  • Summarizing metastatic biological processes and nanomaterial-based intervention strategies.
  • Analyzing nanomaterial applications targeting the TME, CTCs, and PMN.
  • Reviewing current literature on nanomaterials for cancer metastasis prevention.

Main Results:

  • Nanomaterials can be utilized to interrupt metastatic processes by acting on the TME, CTCs, and PMN.
  • Multifunctional nanomaterials show significant advantages for long-term metastasis prevention.
  • Targeting multiple aspects of metastasis with nanomaterials can enhance efficacy.

Conclusions:

  • Nanomaterials provide a versatile platform for developing novel strategies against tumor metastasis.
  • Continued exploration of nanomaterial-based approaches will accelerate progress in cancer prevention, diagnosis, and treatment.
  • Developing effective nanomaterial strategies is crucial for improving cancer patient outcomes.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K